CBUS vs CTVA
CBUS: Cibus is a gene-editing biotechnology company that licenses proprietary agricultural productivity traits and develops sustainable plant-based ingredients for the global seed and consumer markets. CTVA: A leading agricultural company developing and commercializing seeds, crop protection chemicals, and agronomic solutions to improve crop yields and farm productivity globally.
Side-by-side fundamentals
| Metric | CBUS | CTVA | Edge |
|---|---|---|---|
| Price as of 2026-07-22 close | $1.79 | $88.53 | |
| Market cap as of 2026-07-23 | $135M | $59.0B | |
| P/E as of 2026-07-23 | n/a | 50.81 | |
| PEG as of 2026-07-23 | n/a | 3.98 | |
| Net margin as of 2026-07-23 | -2366.3% | +6.5% | CTVA higher |
| Gross margin as of 2026-07-23 | +100.0% | +48.6% | CBUS higher |
| Operating margin as of 2026-07-23 | -1588.4% | +15.0% | CTVA higher |
| ROE as of 2026-07-23 | -225.6% | +4.7% | CTVA higher |
| ROA as of 2026-07-23 | -31.1% | +2.7% | CTVA higher |
| Debt / equity as of 2026-07-23 | 6.89 | 0.14 | CTVA lower |
| Revenue growth (YoY) as of 2026-07-23 | -9.8% | +6.3% | CTVA higher |
| Revenue CAGR (3y) SEC XBRL | +185.1% | -0.1% | CBUS higher |
| Dividend yield as of 2026-07-23 | n/a | +0.8% | |
| Dividend streak (yrs) SEC XBRL | n/a | 5 | |
| Beta as of 2026-07-23 | 1.71 | 0.57 | |
| 1-year return as of 2026-07-22 close | +12.7% | +20.0% | CTVA higher |
Fundamentals: Finnhub, as of 2026-07-23. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-07-22.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & Finnhub, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.